会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CONTROLLED PUPIL DILATION FOR DIAGNOSTIC AND TREATMENT OF VISUAL ANOMALIES
    • 用于诊断和治疗视觉异常的控制对位放大器
    • US20080177247A1
    • 2008-07-24
    • US11971851
    • 2008-01-09
    • Rick Lewis
    • Rick Lewis
    • A61M35/00
    • A61K31/137A61K9/0048A61K31/4174
    • Methods and compositions are disclosed for topically applying an ophthalmic solution to the eye to at least temporarily reduce the effects of various visual anomalies. The solution contains a therapeutically effective amount of one or more pupil dilating agents that generate a moderate amount of dilation in order to relieve symptoms such as vitreous floaters. Moreover, the composition may be topically applied in approximately a one drop dose, which may be instilled on an as needed basis depending on the concentration and rate of release of one or more of the following or similar dilating agents: naphazoline, ephedrine, naphazoline HCl, phenylephrine HCl, epinephrine and/or dipivefrin.
    • 公开了用于将眼用溶液局部施用于眼睛以至少暂时降低各种视觉异常的影响的方法和组合物。 溶液含有治疗有效量的一种或多种瞳孔扩张剂,其产生中度量的扩张以便缓解诸如玻璃体浮游物的症状。 此外,组合物可以以大约一滴剂量局部施用,其可以根据需要滴注,这取决于一种或多种以下或类似的扩张剂的释放的浓度和速率:萘甲唑啉,麻黄碱,萘唑啉HCl ,盐酸去氧肾上腺素,肾上腺素和/或dipiffrin。
    • 3. 发明申请
    • Controlled pupil dilation for diagnostic and treatment of visual anomalies
    • 控制瞳孔扩张用于诊断和治疗视觉异常
    • US20070154523A1
    • 2007-07-05
    • US11324128
    • 2005-12-30
    • Rick Lewis
    • Rick Lewis
    • A61K31/137A61F2/02
    • A61K31/137A61K9/0048A61K31/4174
    • Methods and compositions are disclosed for topically applying an ophthalmic solution to the eye to at least temporarily reduce the effects of various visual anomalies. The solution contains a therapeutically effective amount of one or more pupil dilating agents that generate a moderate amount of dilation in order to relieve symptoms such as vitreous floaters. Moreover, the composition may be topically applied in approximately a one drop dose, which may be instilled on an as needed basis depending on the concentration and rate of release of one or more of the following or similar dilating agents: naphazoline, ephedrine, naphazoline HCl, phenylephrine HCl, epinephrine and/or dipivefrin.
    • 公开了用于将眼用溶液局部施用于眼睛以至少暂时降低各种视觉异常的影响的方法和组合物。 溶液含有治疗有效量的一种或多种瞳孔扩张剂,其产生中度量的扩张以便缓解诸如玻璃体浮游物的症状。 此外,组合物可以以大约一滴剂量局部施用,其可以根据需要滴注,这取决于一种或多种以下或类似的扩张剂的释放的浓度和速率:萘甲唑啉,麻黄碱,萘唑啉HCl ,盐酸去氧肾上腺素,肾上腺素和/或dipiffrin。